161 related articles for article (PubMed ID: 6145533)
21. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
24. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
Rönn O; Johnsson G; Lundborg P
J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
[TBL] [Abstract][Full Text] [Related]
25. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man.
Lyrenäs E; Abrahamsson H; Dotevall G
Scand J Gastroenterol; 1985 Dec; 20(10):1169-74. PubMed ID: 2869574
[TBL] [Abstract][Full Text] [Related]
26. Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.
Svendsen TL; Hartling OJ; Trap-Jensen J
Eur J Clin Pharmacol; 1980 Oct; 18(3):219-23. PubMed ID: 6108219
[TBL] [Abstract][Full Text] [Related]
27. Effect of prenalterol in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the cardiac effects of beta-adrenoreceptor agonists in anaesthetised and conscious dogs.
Einstein R; Goodman AH; Yeoh EB
J Auton Pharmacol; 1986 Mar; 6(1):9-14. PubMed ID: 3957953
[TBL] [Abstract][Full Text] [Related]
29. Effects of beta-adrenoceptor stimulation on rectosigmoid motility in man.
Lyrenäs E; Abrahamsson H; Dotevall G
Dig Dis Sci; 1985 Jun; 30(6):536-40. PubMed ID: 2859970
[TBL] [Abstract][Full Text] [Related]
30. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic effects of prenalterol in healthy subjects.
Johnsson G
Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
[No Abstract] [Full Text] [Related]
33. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
[TBL] [Abstract][Full Text] [Related]
34. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
35. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
Greefhorst AP; van Herwaarden CL
Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
[TBL] [Abstract][Full Text] [Related]
36. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
[TBL] [Abstract][Full Text] [Related]
37. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
McCaffrey PM; Riddell JG; Shanks RG
Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
[TBL] [Abstract][Full Text] [Related]
38. Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
Kirlin PC; Romson JL; Pitt B; Lucchesi B
Pharmacology; 1984; 28(1):51-60. PubMed ID: 6701187
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
40. Inotropic effect of prenalterol in amitriptyline poisoning.
Heath A; Mårin P; Sjöstrand I
Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
